HA-Bayer---Usenov-Nursultan---Header

WFH Humanitarian Aid Program: prophylaxis supports a dream in Kyrgyzstan

The WFH Humanitarian Aid Program works with national member organizations (NMOs) and hemophilia treatment centres (HTCs) around the world to support people with bleeding disorders (PWBDs) so that they can live more normal lives. The Program aims to provide sustainable care—not just one-off donations. The goal is that PWBDs can have consistent access to support so that they can live more normal lives. Usenov Nursultan is an 18-year-old from Kyrgyzstan. Thanks to WFH Humanitarian Aid Program donated treatment products, he hopes to one day become a medical doctor.

Also available in: Français Español

Nursultan has severe hemophilia A. Because he received minimal treatment as a child, he suffered from frequent bleeds, and, as a result, he has arthropathy of both knee joints. His brother also has hemophilia. Living with hemophilia—and seeing how it affected both himself and his brother—instilled in Nursultan a strong desire to try and make a difference by becoming a physician. 

Despite continuing bleeds in his knees, Nursultan was able to study hard and was accepted to medical school. His hard work continued there, and he progressed in his studies—but missed school because of bleeds in his knees. At this point, the specialists at the hemophilia treatment centre (HTC) suggested that he go on low-dose short-term secondary prophylaxis with factor concentrate—provided by the WFH Humanitarian Aid Program—to minimize further school absences. The treatment was successful: acute bleeds stopped almost entirely, and he was able to concentrate fully on his medical studies. The therapy also improved Nursultan’s quality of life drastically. The success of this prophylactic treatment in Kyrgyzstan is further proof that predictable donations can help make sustainable care possible.

Since 2015, nearly 28 million IUs of factor have been donated to Kyrgyzstan. Just over 3.3 million IUs of factor were donated in 2022 alone. To find out more about the WFH Humanitarian Aid Program, please click here.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and Takeda and Japan Blood Products Organization, our Contributors. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.